Overactive Bladder - Results from #340

REVIEW UroToday

Clinical preferences and treatment attitudes among urologists, gynecologists, and geriatricians: An independent online questionnaire survey for comparison of treatment choices in the management of overactive bladder. October 9, 2022

Quality of life in patients with overactive bladder following botulinum toxin treatment: a preliminary report. October 9, 2022

A Feasibility Study to Evaluate Changes in Urinary Metabolites after OnabotulinumtoxinA Injection for Refractory Overactive Bladder. October 2, 2022

Urinary Levels of miR-491-5p and miR-592 as Potential Diagnostic Biomarkers in Female Aging Patients with OAB: A Pilot Study. October 2, 2022

Vitamin D supplements and prevalent overactive bladder in women from midlife through older ages. October 2, 2022

An analysis of factors that influence patient preference of third-line therapy for overactive bladder. September 25, 2022

Efficacy and safety of transurethral resection of the prostate, holmium laser enucleation of the prostate, and photoselective vaporization of the prostate in management of overactive bladder symptoms complicating benign prostatic hyperplasia in patients w September 25, 2022

Peroneal electrical transcutaneous neuromodulation in the home treatment of the refractory overactive bladder. September 25, 2022

Vibegron for the treatment of overactive bladder: a comprehensive update. September 25, 2022

Agreement between the visual analogue scale (VAS) and the dysfunctional voiding scoring system (DVSS) in the post-treatment evaluation of electrical nerve stimulation in children and adolescents with overactive bladder. September 25, 2022

Mirabegron in the Management of Overactive Bladder Syndrome. September 25, 2022

Acupuncture for treating overactive bladder in adults. September 25, 2022

Medical Treatment of Overactive Bladder. September 18, 2022

Effects of Pelvic Floor Muscle Training on Sexual Dysfunction, Sexual Satisfaction of Partners, Urinary Symptoms, and Pelvic Floor Muscle Strength in Women With Overactive Bladder: A Randomized Controlled Study. September 18, 2022

Mirabegron and antimuscarinic use in frail overactive bladder patients in the United States Medicare population. September 18, 2022

Effect of Vitamin D Supplementation on Overactive Bladder and Urinary Incontinence Symptoms in Older Men: Ancillary Findings from a Randomized Trial. September 18, 2022

Physical Agent-Based Treatments for Overactive Bladder: A Review. September 11, 2022

Efficacy of Yun-type pelvic floor optimal training therapy and PFMT on middle aged women with mild to moderate overactive bladder: a randomized controlled trial. September 11, 2022

SUFU white paper on overactive bladder anticholinergic medications and dementia risk. September 11, 2022

Exposure to DEHP is potential to increase the risk of overactive bladder, evidence from NHANES 2003-2008. September 4, 2022

Page 18 of 121